| [1] |
Weidinger S, Novak N. Hand eczema[J]. Lancet, 2024,404(10470):2476⁃2486. DOI: 10.1016/S0140⁃6736(24)01810⁃5.
|
| [2] |
中国医师协会皮肤科医师分会科学委员会, 中国医师协会皮肤科医师分会变态反应性疾病专业委员会, 中国"手部湿疹科研协作组". 中国手部湿疹诊疗专家共识(2021版)[J]. 中华皮肤科杂志, 2021,54(1):19⁃26. DOI: 10.35541/cjd.2020 0281.
|
| [3] |
Quaade AS, Simonsen AB, Halling AS, et al. Prevalence, incidence, and severity of hand eczema in the general population - a systematic review and meta⁃analysis[J]. Contact Dermatitis, 2021,84(6):361⁃374. DOI: 10.1111/cod.13804.
|
| [4] |
Voorberg AN, Loman L, Schuttelaar M. Prevalence and severity of hand eczema in the Dutch general population: a cross⁃sectional, questionnaire study within the lifelines cohort study[J]. Acta Derm Venereol, 2022,102:adv00626. DOI: 10.2340/actadv.v101.432.
|
| [5] |
Apfelbacher C, Bewley A, Molin S, et al. Prevalence of chronic hand eczema in adults: a cross⁃sectional survey of over 60 000 respondents from the general population of Canada, France, Germany, Italy, Spain and the UK[J]. Br J Dermatol, 2025,192(6):1047⁃1054. DOI: 10.1093/bjd/ljaf020.
|
| [6] |
王鑫, 杨明川, 石晓东, 等. 三甲医院皮肤科门诊手部湿疹患者横断面多中心调查[J]. 实用皮肤病学杂志, 2019,12(2):65⁃67. DOI: 10.11786/sypfbxzz.1674⁃1293.20190201.
|
| [7] |
Jamil W, Svensson Å, Josefson A, et al. Incidence rate of hand eczema in different occupations: a systematic review and meta⁃analysis[J]. Acta Derm Venereol, 2022,102:adv00681. DOI: 10.2340/actadv.v102.360.
|
| [8] |
Sedeh FB, Michaelsdottir TE, Christiensen KB, et al. Prevalence and risk factors for hand eczema among professional hospital cleaners in Denmark: a cross⁃sectional questionnaire⁃based study[J]. Contact Dermatitis, 2023,89(4):241⁃249. DOI: 10.1111/cod.14379.
|
| [9] |
Havmose MS, Kezic S, Uter W, et al. Prevalence and incidence of hand eczema in hairdressers⁃a systematic review and meta⁃analysis of the published literature from 2000⁃2021[J]. Contact Dermatitis, 2022,86(4):254⁃265. DOI: 10.1111/cod.14048.
|
| [10] |
Yüksel YT, Symanzik C, Christensen MO, et al. Prevalence and incidence of hand eczema in healthcare workers: a systematic review and meta⁃analysis[J]. Contact Dermatitis, 2024,90(4):331⁃342. DOI: 10.1111/cod.14489.
|
| [11] |
Huang D, Tang Z, Qiu X, et al. Hand eczema among healthcare workers in Guangzhou city: a cross⁃sectional study[J]. Ann Transl Med, 2020,8(24):1664. DOI: 10.21037/atm⁃20⁃7652.
|
| [12] |
Qu Z, Jiang Q, Wang B, et al. A cross⁃sectional study of clinical characteristics and risk factors for hand eczema in the general Chinese population[J]. Sci Rep, 2024,14(1):29733. DOI: 10. 1038/s41598⁃024⁃81610⁃9.
|
| [13] |
Siewertsen M, Näslund⁃Koch C, Duus Johansen J, et al. Psychological burden, anxiety, depression and quality of life in patients with hand eczema: a systematic review and meta⁃analysis[J]. J Eur Acad Dermatol Venereol, 2024,38(11):2110⁃2117. DOI: 10.1111/jdv.20140.
|
| [14] |
Armstrong A, Hahn⁃Pedersen J, Bartlett C, et al. Economic burden of chronic hand eczema: a review[J]. Am J Clin Dermatol, 2022,23(3):287⁃300. DOI: 10.1007/s40257⁃021⁃00669⁃6.
|
| [15] |
Zalewski A, Krajewski PK, Szepietowski JC. Prevalence and characteristics of itch and pain in patients suffering from chronic hand eczema[J]. J Clin Med, 2023,12(13):4198. DOI: 10.3390/jcm12134198.
|
| [16] |
Asamoah N, Branyiczky MK, Almuqrin A, et al. Efficacy and safety of dupilumab in chronic hand eczema: a systematic review[J]. Arch Dermatol Res, 2025,317(1):441. DOI: 10.1007/s00403⁃025⁃03947⁃z.
|
| [17] |
Ruff SMD, Engebretsen KA, Zachariae C, et al. The association between atopic dermatitis and hand eczema: a systematic review and meta⁃analysis[J]. Br J Dermatol, 2018,178(4):879⁃888. DOI: 10.1111/bjd.16147.
|
| [18] |
Wang J, Tischer C, Standl M, et al. Lifetime prevalence and determinants of hand eczema in an adolescent population in Germany: 15⁃year follow⁃up of the LISA cohort study[J]. J Eur Acad Dermatol Venereol, 2022,36(4):547⁃556. DOI: 10.1111/jdv.17814.
|
| [19] |
Liang Y, Zhang X, Zhu J, et al. Analysis of patch testing in patients with hand eczema at Shenzhen from 2016 to 2019[J]. Postepy Dermatol Alergol, 2021,38(2):170⁃172. DOI: 10.5114/ada.2021.104294.
|
| [20] |
Ho J, Molin S. A review of existing and new treatments for the management of hand eczema[J]. J Cutan Med Surg, 2023,27(5):493⁃503. DOI: 10.1177/12034754231188325.
|
| [21] |
Dubin C, Del Duca E, Guttman⁃Yassky E. Drugs for the treatment of chronic hand eczema: successes and key challenges[J]. Ther Clin Risk Manag, 2020,16:1319⁃1332. DOI: 10.2147/TCRM.S292504.
|
| [22] |
Abdelhalim A, Yilmaz O, Elshaikh Berair M, et al. Topical delgocitinib for the treatment of chronic hand eczema[J]. J Dermatolog Treat, 2025,36(1):2479126. DOI: 10.1080/09546634. 2025.2479126.
|
| [23] |
Zalewski A, Szepietowski JC. Topical and systemic JAK inhibitors in hand eczema ⁃ a narrative review[J]. Expert Rev Clin Immunol, 2023,19(4):365⁃373. DOI: 10.1080/1744666X.2023.2174526.
|
| [24] |
Christensen MO, Sieborg J, Nymand L K, et al. Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema⁃findings from the Danish skin cohort[J]. J Am Acad Dermatol, 2024,91(6):1094⁃1103. DOI: 10. 1016/j.jaad.2024.07.1503.
|
| [25] |
Gooderham M, Molin S, Bissonnette R, et al. Long⁃term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with chronic hand eczema: results of the phase 3 open⁃label extension DELTA 3 trial following the DELTA 1 and 2 trials[J]. J Am Acad Dermatol, 2025,93(1):95⁃103. DOI: 10.1016/j.jaad. 2025.03.008.
|
| [26] |
Gomez⁃Martinez S, Amat⁃Samaranch V, Lasheras⁃Pérez MA, et al. Oral roflumilast for the treatment of chronic hand eczema: a retrospective case series[J]. J Am Acad Dermatol, 2025,93(2):489⁃491. DOI: 10.1016/j.jaad.2025.04.062.
|
| [27] |
Riva HR, Yoon T, Hendricks AJ, et al. Dupilumab for chronic hand eczema: a systematic review and meta⁃analysis[J]. Dermatitis, 2026, 37(1):20⁃41. DOI: 10.1089/derm.2024.0186.
|
| [28] |
Park JB, Lee SH, Kim KJ, et al. Clinical features and awareness of hand eczema in Korea[J]. Ann Dermatol, 2016,28(3):335⁃343. DOI: 10.5021/ad.2016.28.3.335.
|
| [29] |
Szepietowska M, Dabrowska A, Dziasek S, et al. Adolescents' knowledge and attitudes related to hand eczema: a cross⁃sectional study[J]. Clin Cosmet Investig Dermatol, 2023,16:1963⁃1967. DOI: 10.2147/CCID.S418352.
|
| [31] |
Seol JE, Kim JU, Hong SM, et al. Alitretinoin compliance in patients with chronic hand eczema[J]. Ann Dermatol, 2021,33(1):46⁃51. DOI: 10.5021/ad.2021.33.1.46.
|
| [32] |
Makowska K, Nowaczyk J, Samochocki Z, et al. Topical proactive therapy in dermatology. A scoping review[J]. Postepy Dermatol Alergol, 2023,40(4):510⁃517. DOI: 10.5114/ada.2023. 129454.
|
| [33] |
Bauer A, Brans R, Brehler R, et al. S2k guideline diagnosis, prevention, and therapy of hand eczema[J]. J Dtsch Dermatol Ges, 2023,21(9):1054⁃1074. DOI: 10.1111/ddg.15179.
|
| [34] |
Hon KL, Tsang YC, Pong NH, et al. Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema[J]. J Dermatolog Treat, 2015,26(5):418⁃425. DOI: 10.3109/09546634.2015.1025030.
|
| [35] |
Reich A, Wilke A, Gediga G, et al. Health education decreases incidence of hand eczema in metal work apprentices: results of a controlled intervention study[J]. Contact Dermatitis, 2020,82(6):350⁃360. DOI: 10.1111/cod.13502.
|